Trial of Gemcitabine_Capecitabine Versus Gemcitabine_Carboplatin in Breast Cancer
NCT02207335
·
clinicaltrials.gov ↗
PHASE3
Phase
UNKNOWN
Status
120
Enrollment
OTHER
Sponsor class
Conditions
Metastatic Breast Cancer
Interventions
DRUG:
Gemcitabine，Capecitabine
DRUG:
Gemcitabine, Carboplatin
Sponsor
Tianjin Medical University Cancer Institute and Hospital